https://websites4-live-prod.ysmdevs.com/lab/hinchcliff/news-rss/?orgId=119558&title=Latest+News A selection of the latest research, academic, and other newsworthy developments at Hinchcliff Lab en-us Copyright 2026 Yale School of Medicine Thu, 14 May 2026 20:14:40 Z https://websites4-live-prod.ysmdevs.com/lab/hinchcliff/news-article/systemic-sclerosis-ai-deep-neural-networks/ https://websites4-live-prod.ysmdevs.com/lab/hinchcliff/news-article/systemic-sclerosis-ai-deep-neural-networks/ In a new Yale-led study, researchers used a type of AI technology called deep neural network (DNN) analysis to decipher skin involvement and treatment response in patients with systemic sclerosis. Thu, 24 Apr 2025 04:00:00 Z https://websites4-live-prod.ysmdevs.com/lab/hinchcliff/news-article/test-could-help-identify-patients-at-risk-severe-scleroderma/ https://websites4-live-prod.ysmdevs.com/lab/hinchcliff/news-article/test-could-help-identify-patients-at-risk-severe-scleroderma/ A new Yale study points to type 1 interferons as a potential biomarker for scleroderma patients with a worse prognosis. Wed, 09 Apr 2025 15:00:00 Z https://websites4-live-prod.ysmdevs.com/lab/hinchcliff/news-article/yale-faculty-interstitial-lung-disease-guideline/ https://websites4-live-prod.ysmdevs.com/lab/hinchcliff/news-article/yale-faculty-interstitial-lung-disease-guideline/ Four faculty members from the Yale School of Medicine Department of Internal Medicine were involved in developing a national guideline for the screening, monitoring, and treatment of interstitial lung disease in patients with rheumatic conditions. Tue, 28 Jan 2025 18:55:00 Z https://websites4-live-prod.ysmdevs.com/lab/hinchcliff/news-article/hyaluronic-acid-lip-fillers-safe-scleroderma/ https://websites4-live-prod.ysmdevs.com/lab/hinchcliff/news-article/hyaluronic-acid-lip-fillers-safe-scleroderma/ Hyaluronic acid lip fillers are safe and effective for patients with systemic sclerosis, or scleroderma, a new Yale study finds. The study was directed by Kathleen Suozzi, MD, associate professor of dermatology, and Monique Hinchcliff, MD, MS, associate professor of medicine (rheumatology, allergy & immunology) and director of the Yale Scleroderma Program. Mon, 15 Jul 2024 04:00:00 Z https://websites4-live-prod.ysmdevs.com/lab/hinchcliff/news-article/what-to-know-about-scleroderma/ https://websites4-live-prod.ysmdevs.com/lab/hinchcliff/news-article/what-to-know-about-scleroderma/ June is World Scleroderma Month. To mark the occasion, Monique Hinchcliff, MD, MS, associate professor of medicine (rheumatology, allergy and immunology) and director of the Yale Scleroderma Program, discusses four things to know about the disease. Thu, 13 Jun 2024 19:36:00 Z https://www.wtnh.com/on-air/nyberg/nyberg-talking-about-scleroderma-awareness-month/ https://www.wtnh.com/on-air/nyberg/nyberg-talking-about-scleroderma-awareness-month/ June is Scleroderma Awareness Month. Monique Hinchcliff, MD, MS, associate professor of medicine (rheumatology, allergy and immunology) and director of the Yale Scleroderma Program, talks with Ann Nyberg about the disease. Thu, 13 Jun 2024 04:00:00 Z https://websites4-live-prod.ysmdevs.com/lab/hinchcliff/news-article/fellow-focus-in-four-krishnasai-abhishek-madathanapalli-md-rheumatology/ https://websites4-live-prod.ysmdevs.com/lab/hinchcliff/news-article/fellow-focus-in-four-krishnasai-abhishek-madathanapalli-md-rheumatology/ Meet Krishnasai Abhishek Madathanapalli, MD, a clinical fellow in the Section of Rheumatology, Allergy and Immunology at Yale School of Medicine, who was born in Bahrain and grew up experiencing many different environments and cultures. Thu, 14 Mar 2024 13:59:00 Z https://websites4-live-prod.ysmdevs.com/lab/hinchcliff/news-article/treating-threatened-digit-loss-due-to-raynaud-phenomenon/ https://websites4-live-prod.ysmdevs.com/lab/hinchcliff/news-article/treating-threatened-digit-loss-due-to-raynaud-phenomenon/ In a new outpatient treatment at Yale, infusions are safely given to patients whose fingers and toes are damaged by severe Raynaud phenomenon, also known as Raynaud’s phenomenon, to prevent amputation. Previously, these patients were sent to the emergency department, where they often waited for days before receiving treatment. Tue, 29 Aug 2023 15:17:00 Z https://websites4-live-prod.ysmdevs.com/lab/hinchcliff/news-article/discoveries-and-impact-june-2023/ https://websites4-live-prod.ysmdevs.com/lab/hinchcliff/news-article/discoveries-and-impact-june-2023/ Discoveries & Impact highlights select scientific discoveries across the Department of Internal Medicine... Mon, 05 Jun 2023 04:00:00 Z